| 22287/34351 | US=38 / Biol/Mol Saw CL, Heaney DL, Gebel HM, Bray RA. Relevance of antibody screening and crossmatching and solid organ, hematopoietic stem cell transplantation, and blood transfusion. In: O'Gorman MRG, Donnenbeg AD. Handbook of human immunology. 2 ed. Boca Raton: CRC, 2008. p. 565-88. ISBN 978-0-8493-1984-6. PESQUISA DE ANTICORPOS; CROSSMATCHING; ORGAOS SOLIDOS; TRANSPLANTE DE CELULAS-TRONCO HEMATOPOETICAS; TRANSFUSAO DE SANGUE |
| 22288/34351 | US=38 / Biol/Mol Kumar CA, Abdullah A, Logar A, Wilson P, Talukdar A, Chien N, Singh M, Sindhi R. Functional assessment of immunosuppression: monitoring posttransplant alloreactivity with flow cytometric mixed lymphocyte cocultures. In: O'Gorman MRG, Donnenbeg AD. Handbook of human immunology. 2ª ed. Boca Raton: CRC, 2008. p. 589-98. ISBN 978-0-8493-1984-6. AVALIACAO FUNCIONAL DE IMUNOSSUPRESSAO; ACOMPANHAMENTO POS-TRANSPLANTE; ALLOREACTIVITY DE CITOMETRIA; FLUXO DE LINFOCITOS MISTOS COCULTURAS |
| 22289/34351 | US=39 / Câncer Vollmers HP, Brändlein S. Sensitization of epithelial cancer cells with human monoclonal antibodies. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 3-11. ISBN 978-1-58829-989-5. CELULAS CANCEROSAS EPITELIAIS; ANTICORPOS MONOCLONAIS HUMANOS; ANTICORPOS NATURAIS IGM; FATOR DE RECEPTORES DE CRESCIMENTO; FATOR DE ACELERACAO DO DECAIMENTO; PROTEINAS DE CHOQUE TERMICO |
| 22290/34351 | US=39 / Câncer Daniels TR, Neacato IL, Helguera G, Penichet ML. Targeting the transferrin receptor to overcome resistance to anti-cancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 13-27. ISBN 978-1-58829-989-5. RECEPTORES-ALVO; TRANSFERRINA; AGENTES ANTICANCERIGENOS; QUIMIORRESISTENCIA |
| 22291/34351 | US=39 / Câncer Bonavida B, Jazirehi AR, Vega MI, Huerta-Yepez S, Umezawa K, Suzuki E. Chemo-immunosensitization of resistant B-NHL as a result of rituximab (anti-CD20 mAb)-mediated inhibition of cell survival signaling pathaways. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 29-39. ISBN 978-1-58829-989-5. SENSIBILIZACAO IMUNITARIO; B-NHL; RITUXIMABE; ANTI-CD20 MAB; SINALIZACAO CELULAR |
| 22292/34351 | US=39 / Câncer Yoshida T, Sakai T. Agents that regulate DR5 and sensitivity to TRAIL. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 41-9. ISBN 978-1-58829-989-5. |
| 22293/34351 | US=39 / Câncer Motarjemi M, Hallett WHD, Li M, Murphy WJ. Proteasome inhibition: potential for sensitization of immune effector mechanisms in cancer. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 51-60. ISBN 978-1-58829-989-5. INIBICAO DO PROTEASSOMA; SENSIBILIZACAO DE MECANISMOS EFETORES IMUNES; CANCER; BORTEZOMIBE; CDDO |
| 22294/34351 | US=39 / Câncer Francia G, Emmenegger U, Kerbel RS. Angiogenesis inhibitors as enabling agents for the chemotherapeutic treatment of metastatic disease. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 63-80. ISBN 978-1-58829-989-5. INIBIDORES DA ANGIOGENESE; TRATAMENTO QUIMIOTERAPEUTICO; DOENCA METASTATICA |
| 22295/34351 | US=39 / Câncer McCubrey JA, Franklin RA, Bertrand FE, Taylor JR, Chappell WH, Sokolosky ML, Wong EWT, Abrams SL, Stadelman KM, Misaghian N, Ludwing DL, Basecke J, Libra M, Stivala F, Milella M, Tafuri A, Martelli AM, Lunghi P, Bonati A, Terrian DM, Lehmann BD, Steelman LS. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK and PI3K/Akt pathways to sensitize cancer cells to therapy. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 81-114. ISBN 978-1-58829-989-5. SEGMENTACAO CASCATAS DE SOBREVIVENCIA; ATIVACAO DE RAS / RAF / MEK / ERK; VIAS PI3K/AKT; SENSIBILIZACAO DAS CELULAS CANCEROSAS; APOPTOSE; CANCER HEMATOPOIETICO |
| 22296/34351 | US=39 / Câncer Rosato RR, Grant S. Histone deacetylase inhibitors and anticancer activity. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 115-31. ISBN 978-1-58829-989-5. INIBIDORES HISTONA DEACETILASE; ATIVIDADE ANTICANCER; MECANISMO MOLECULAR; EPIGENETICA |
| 22297/34351 | US=39 / Câncer Sorokin A. Eicosanoids and resistance of cancer cells to chemotherapeutic agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 133-56. ISBN 978-1-58829-989-5. EICOSANOIDES; RESISTENCIA DAS CELULAS CANCEROSAS; AGENTES QUIMIOTERAPEUTICOS; SINTESE CELULAR DE EICOSANOIDES; ACIDO ARAQUIDONICO |
| 22298/34351 | US=39 / Câncer Chatterjee D, Sabo E, Resnick MB, Yeung KC, Chin YE. The RKIP and STAT3 axis in cancer chemotherapy: opposites attract. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 159-74. ISBN 978-1-58829-989-5. RKIP; STAT3; QUIMIOTERAPIA; CANCER; APOPTOSE; NF-KB; VIA JAK/STAT; RKIP |
| 22299/34351 | US=39 / Câncer Gambari R. Targeting transcription factors with decoy oligonucleotideos: modulation of the expression of genes involved in chemotherapy resistance of tumor cells. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 175-87. ISBN 978-1-58829-989-5. FATORES DE TRANSCRICAO; OLIGONUCLEOTIDEOS DE ENGODO; MODULACAO DA EXPRESSAO DE GENES; RESISTENCIA A QUIMIOTERAPIA; CELULAS TUMORAIS |
| 22300/34351 | US=39 / Câncer Maina F, Dono R. p53 inhibitors as cancer sensitizing agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 189-202. ISBN 978-1-58829-989-5. |
| 22301/34351 | US=39 / Câncer Bonavida B, Huerta-Yepez S, Vega MI, Spandidos DA, Baritaki S. Nitric oxide-induced immunosensitization to apoptosis by Fas-L and TRAIL. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 203-10. ISBN 978-1-58829-989-5. |
| 22302/34351 | US=39 / Câncer Jagetia G, Krishnan S, Aggarwal BB. Natural agents that can sensitize tumor cells to chemotherapy and radiation therapy. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 211-40. ISBN 978-1-58829-989-5. SENSIBILIZACAO DE CELULAS TUMORAIS; AGENTES NATURAIS; QUIMIOTERAPIA; TERAPIA POR RADIACAO; QUIMIORRESISTENCIA; RADIORESISTENCIA; POLIFENOIS RADIOSENSIVEIS |
| 22303/34351 | US=39 / Câncer Johnson DE. Inhibitors of the Bcl-2 protein family as sensitizers to anticancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 243-61. ISBN 978-1-58829-989-5. INIBIDORES BCL-2; AGENTES ANTICANCERIGENOS; APOPTOSE; PEPTIDEOS BH3 |
| 22304/34351 | US=39 / Câncer Wilson TR, Longley DB, Johnston PG. Therapeutic targeting of apoptosis in cancer. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 263-78. ISBN 978-1-58829-989-5. |
| 22305/34351 | US=39 / Câncer Banerji S, Ande SR, Maddika S, Banerji V, Rashedi I, Owens NW, Zuse A, Schweizer F, Los M. Peptides and peptidomimetics as cancer therapy sensitizing agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 279-303. ISBN 978-1-58829-989-5. PEPTIDOS; PEPTIDOMIMETICOS; AGENTES SENSIBILIZANTES; TERAPIA DO CANCRO |
| 22306/34351 | US=39 / Câncer Dings RPM, Klein M, Mayo KH. Non-peptidic mimetics as cancer-sensitizing agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 305-25. ISBN 978-1-58829-989-5. AGENTES SENSIBILIZADORES NAO-PEPTIDICOS MIMETICOS; CANCER; TERAPEUTICA DE COMBINACAO |